Cas no 52951-09-4 (1-benzofuran-7-carbonitrile)
1-benzofuran-7-carbonitrile Chemical and Physical Properties
Names and Identifiers
-
- 7-Benzofurancarbonitrile
- benzofuran-7-carbonitrile
- 1-Benzofuran-7-carbonitril
- 1-benzofuran-7-carbonitrile
- AS-6374
- CS-0453369
- SY027225
- EN300-267828
- CCA95109
- DB-229868
- A856695
- MFCD15143950
- F20168
- SCHEMBL3203940
- SB22956
- AKOS022966233
- 52951-09-4
-
- MDL: MFCD15143950
- Inchi: 1S/C9H5NO/c10-6-8-3-1-2-7-4-5-11-9(7)8/h1-5H
- InChI Key: HAICRZPDDBKXPQ-UHFFFAOYSA-N
- SMILES: O1C=CC2C=CC=C(C#N)C1=2
Computed Properties
- Exact Mass: 143.03700
- Monoisotopic Mass: 143.037113783g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 2
- Heavy Atom Count: 11
- Rotatable Bond Count: 0
- Complexity: 193
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 2
- Topological Polar Surface Area: 36.9?2
Experimental Properties
- PSA: 36.93000
- LogP: 2.30448
1-benzofuran-7-carbonitrile Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Alichem | A159000020-1g |
Benzofuran-7-carbonitrile |
52951-09-4 | 95% | 1g |
$298.95 | 2023-09-01 | |
| Chemenu | CM324691-1g |
1-Benzofuran-7-carbonitrile |
52951-09-4 | 95% | 1g |
$310 | 2021-06-17 | |
| TRC | B139905-50mg |
Benzofuran-7-carbonitrile |
52951-09-4 | 50mg |
$ 185.00 | 2022-06-07 | ||
| TRC | B139905-100mg |
Benzofuran-7-carbonitrile |
52951-09-4 | 100mg |
$ 300.00 | 2022-06-07 | ||
| SHANG HAI SHAO YUAN SHI JI Co., Ltd. | SY027225-1g |
Benzofuran-7-carbonitrile |
52951-09-4 | ≥95% | 1g |
¥5500.00 | 2024-07-09 | |
| Apollo Scientific | OR470745-1g |
Benzofuran-7-carbonitrile |
52951-09-4 | 1g |
£342.00 | 2025-02-20 | ||
| abcr | AB470352-500 mg |
Benzofuran-7-carbonitrile; 90% |
52951-09-4 | 500mg |
€311.30 | 2023-04-21 | ||
| abcr | AB470352-1 g |
Benzofuran-7-carbonitrile; 90% |
52951-09-4 | 1g |
€452.00 | 2023-04-21 | ||
| Enamine | EN300-267828-1g |
1-benzofuran-7-carbonitrile |
52951-09-4 | 1g |
$212.0 | 2023-09-11 | ||
| Enamine | EN300-267828-5g |
1-benzofuran-7-carbonitrile |
52951-09-4 | 5g |
$618.0 | 2023-09-11 |
1-benzofuran-7-carbonitrile Related Literature
-
Gerald J. Meyer,Leif Hammarstr?m Chem. Sci., 2020,11, 3460-3473
-
Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
-
Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
-
Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084
-
Jing Yu,Yu-Qi Lyu,Jiapeng Liu,Mohammed B. Effat,Junxiong Wu J. Mater. Chem. A, 2019,7, 17995-18002
Additional information on 1-benzofuran-7-carbonitrile
Introduction to 1-benzofuran-7-carbonitrile (CAS No. 52951-09-4)
1-benzofuran-7-carbonitrile, identified by the Chemical Abstracts Service Number (CAS No.) 52951-09-4, is a significant heterocyclic compound that has garnered considerable attention in the field of pharmaceutical chemistry and organic synthesis. This compound belongs to the benzofuran family, a class of molecules characterized by a fused benzene and furan ring system, which exhibits a wide range of biological activities and chemical functionalities. The presence of a nitrile group at the 7-position introduces unique reactivity, making it a valuable intermediate in the synthesis of various pharmacologically active agents.
The structural features of 1-benzofuran-7-carbonitrile contribute to its versatility in medicinal chemistry. The benzofuran core is a privileged scaffold in drug discovery, often found in natural products and synthetic molecules with therapeutic potential. The nitrile functionality serves as a versatile handle for further chemical transformations, including nucleophilic addition reactions, reduction to amides, and coupling reactions via transition metal catalysis. These properties have positioned 1-benzofuran-7-carbonitrile as a key building block in the development of novel therapeutic entities.
In recent years, there has been growing interest in exploring the pharmacological properties of benzofuran derivatives. Studies have demonstrated that modifications at the 7-position of the benzofuran core can significantly influence biological activity. For instance, derivatives with electron-withdrawing groups such as nitriles have shown enhanced binding affinity to certain biological targets. This has led to investigations into 1-benzofuran-7-carbonitrile as a precursor for drugs targeting neurological disorders, inflammatory conditions, and infectious diseases.
One of the most compelling aspects of 1-benzofuran-7-carbonitrile is its role in the synthesis of bioactive molecules. Researchers have leveraged its structural framework to develop compounds with potential applications in oncology, immunology, and metabolic diseases. For example, recent studies have highlighted its utility in generating small-molecule inhibitors that modulate key enzymes involved in cancer progression. The nitrile group at the 7-position allows for facile derivatization, enabling chemists to fine-tune physicochemical properties such as solubility and metabolic stability.
The synthetic accessibility of 1-benzofuran-7-carbonitrile has also contributed to its widespread use in academic and industrial research. Several methodologies have been developed for its preparation, including cyclization reactions from appropriately substituted phenols and cyano-substituted precursors. These synthetic routes are often optimized for scalability and cost-effectiveness, ensuring that researchers can access this compound in sufficient quantities for both preclinical and clinical studies.
Advances in computational chemistry have further enhanced the understanding of 1-benzofuran-7-carbonitrile's reactivity and function. Molecular modeling studies have provided insights into how structural variations influence binding interactions with biological targets. These predictions have guided experimental efforts, leading to the discovery of novel analogs with improved pharmacokinetic profiles. Such computational approaches are becoming increasingly integral to modern drug discovery pipelines.
The pharmaceutical industry has also recognized the potential of 1-benzofuran-7-carbonitrile as an intermediate for large-scale production. Its incorporation into drug candidates has resulted in several candidates entering clinical trials for various indications. The compound's ability to serve as a versatile scaffold has been particularly valuable in addressing unmet medical needs where traditional pharmacophores have limitations.
In conclusion, 1-benzofuran-7-carbonitrile (CAS No. 52951-09-4) represents a cornerstone molecule in medicinal chemistry due to its structural versatility and functional reactivity. Its role as a precursor for bioactive compounds continues to drive innovation across multiple therapeutic areas. As research progresses, further exploration of its derivatives promises to yield novel treatments that address complex diseases.
52951-09-4 (1-benzofuran-7-carbonitrile) Related Products
- 1136-77-2(Dibenzofuran,4,6-dimethyl-)
- 17059-52-8(7-Methylbenzofuran)
- 55877-31-1(1-Benzofuran-3-carbonitrile)
- 79002-39-4(1-Benzofuran-5-carbonitrile)
- 64965-91-9(Benzofuran,5,7-dimethyl-)
- 515163-42-5(2-methyl-7-Benzofurancarbonitrile)
- 150612-64-9(5-Benzofurancarbonitrile,3-methyl-)
- 51412-72-7(4-Dibenzofurancarbonitrile)
- 7320-53-8(Dibenzofuran, 4-methyl-)
- 17450-68-9(BENZOFURAN-6-CARBONITRILE)